Martin E. Dowty
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions
Papers in
- Pharmacology 16
- Pharmacogenetics and Drug Metabolism 12
- Oncology 29
- Cytokine Signaling Pathways and Interactions 14
- Drug Transport and Resistance Mechanisms 9
- Co-authors
- Sriram Krishnaswami (6 shared papers)Michael I. Jesson (4 shared papers)Jon A. Wolff (3 shared papers)Debra M. Meyer (3 shared papers)Nandini N. Kishore (3 shared papers)Phillip A. Williams (2 shared papers)Sujatha S. Menon (3 shared papers)Jean‐Baptiste Telliez (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (11 papers)Drug Metabolism and Disposition (6 papers)Clinical Pharmacology & Therapeutics (5 papers)The Journal of Clinical Pharmacology (5 papers)Pharmaceutical Research (4 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Martin E. Dowty
68 papers receiving 4.0k citations
Martin E. Dowty's Hit Papers
Peers
Comparison fields: 5 of 119
- Rheumatology 831
- Oncology 1.1k
- Pharmacology 354
- Immunology 831
- Genetics 382
Countries citing papers authored by Martin E. Dowty
This map shows the geographic impact of Martin E. Dowty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin E. Dowty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin E. Dowty more than expected).
Fields of papers citing papers by Martin E. Dowty
This network shows the impact of papers produced by Martin E. Dowty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin E. Dowty. The network helps show where Martin E. Dowty may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin E. Dowty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550) Hit paper breakdown → | 2011 | 561 |
| 2 | Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis Hit paper breakdown → | 2010 | 420 |
| 3 | The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Hit paper breakdown → | 2016 | 319 |
| 4 | 1995 | 235 | |
| 5 | 2014 | 229 | |
| 6 | 1992 | 180 | |
| 7 | 2016 | 165 | |
| 8 | 2018 | 153 | |
| 9 | 2017 | 142 | |
| 10 | 2018 | 140 | |
| 11 | 2007 | 102 | |
| 12 | 2013 | 102 | |
| 13 | 2019 | 93 | |
| 14 | 2016 | 88 | |
| 15 | 2000 | 86 | |
| 16 | 2021 | 83 | |
| 17 | 1992 | 82 | |
| 18 | 2017 | 80 | |
| 19 | 2018 | 68 | |
| 20 | 2000 | 62 |
About Martin E. Dowty
Martin E. Dowty is a scholar working on Pharmacology, Oncology, Immunology, Genetics and Rheumatology, having authored 69 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (14 papers), Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (9 papers), Biosimilars and Bioanalytical Methods (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Receptor Mechanisms and Signaling (7 papers), Biochemical Analysis and Sensing Techniques (5 papers) and Dermatology and Skin Diseases (5 papers). The work is most often cited by research in Rheumatology (831 citations), Oncology (1.1k citations), Pharmacology (354 citations), Immunology (831 citations) and Genetics (382 citations). Martin E. Dowty has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Sriram Krishnaswami, Michael I. Jesson, Jon A. Wolff, Debra M. Meyer, Nandini N. Kishore, Phillip A. Williams, Sujatha S. Menon, Jean‐Baptiste Telliez, James E. Hagstrom and Sarbani Ghosh. Their work appears in journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.